Clinical Trial Update: Intranasal Oxytocin for Methamphetamine Withdrawal in Women [NA]

View source ↗

Summary

A completed clinical trial evaluating intranasal oxytocin for withdrawal in women with methamphetamine use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: Turning Point | Conditions: Methamphetamine Use Disorder | NA | Status: COMPLETED